GlassScriptPhysician profile
Mason D Marcus
NPI 1003300617
$7,839.84
in general payments reported to CMS, 2019-2025
11 companies · $2,821 in 2025
The $2,821 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.81 · 2022: $116 · 2023: $4,048 · 2024: $800 · 2025: $2,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,732 · Food and Beverage: $2,318 · Education: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,731.77 |
| Food and Beverage | $2,317.81 |
| Education | $619.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,622.09 | 2021-2025 | Farapulse, Watchman Access System, Emblem Mri S-Icd |
| Medical Device Business Services, INC. | $2,010.94 | 2023 | Carto 3 |
| Medtronic, INC. | $1,747.24 | 2023-2025 | Advisa Dr Mri Surescan, Micra, Selectsecure |
| Abbott Laboratories | $723.72 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite, Assurity |
| Biotronik INC. | $224.71 | 2022-2023 | Pulsar-18 T3 |
| Biosense Webster, INC. | $179.17 | 2023-2025 | Carto 3 |
| Philips North America LLC | $129.95 | 2025 | Lm Undivided |
| W. L. Gore & Associates, INC. | $79.33 | 2024 | Gore Cardioform Septal Occluder |
| Abiomed | $59.56 | 2024-2025 | Impella |
| Pfizer INC. | $37.20 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.93 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.